Report updated May 5, 2026
PharmEasy - Healthcare App
For indian households seeking convenient, home-delivered access to prescription medicines, diagnostic testing, and affordable medical consultations.
PharmEasy - Healthcare App is a challenged medical app that is free with in-app purchases. With a 4.3/5 rating from 830.2K reviews, it faces significant user friction. Users particularly appreciate customer support representatives provide helpful resolution for refund and return issues, though frequent delivery delays and order cancellations erode trust in the platform remains a common concern.
What is PharmEasy - Healthcare App?
PharmEasy is a medical app for medicine delivery, diagnostic lab booking, and online doctor consultations on iOS and Android.
Users hire the app to manage family healthcare needs from home, seeking to trade the friction of physical pharmacy visits for the convenience of scheduled, discounted delivery.
Current Momentum
v7.7 · today
Maintenance- Improved Product Detail Page speed.
- Enhanced AI-assisted physiotherapy session experience.
Active Nemesis
GoodRx: Prescription Savings
By GoodRx
Other Rivals
7-Day Rank Pulse 🇺🇸
MedicalNo ranking data
Rating Pulse 🇺🇸
Recent User Mood
What makes this app unique?
What Does It Look Like?
What Are The Key Features?
Automated monthly refill reminders and delivery scheduling
Live 1-on-1 sessions with AI-based guidance
In-app comparison tool for lower-cost alternatives
How much does it cost?
- Free access
- Plus membership for extra savings
Monetization relies on retail pharmacy margins, service fees for doctor consultations, and a loyalty subscription program.
Who Built It?
Simplifying healthcare access for Indian households through a unified digital platform for medicine delivery and diagnostic services.
Portfolio
1
Apps
Explore the full 91streets Media Technologies Private report
Portfolio breakdown, audience, momentum, and every app published by 91streets Media Technologies Private.
What do users think recently?
High confidence · 99 reviews analyzed · Based on 99 reviews. Signal may be noisy.
How did the latest release land?
What is the recent mood?
Recent user voice shows a frustrated sentiment. Users appreciate customer support representatives provide helpful resolution for refund and return issues, but report frequent delivery delays and order cancellations erode trust in the platform.
What Users Love
What Frustrates Users
What Users Want
View the full user-sentiment analysis
Mood gauge, ratings & review-volume history, every praise / complaint / request, and sentiment over time.
What is the competitive landscape for PharmEasy - Healthcare App?
How's The Medical Market?
How does it evolve in the Medical market?
PharmEasy maintains a high-volume presence in the Indian medical category, with over 829,000 ratings on Android. The gap between its broad service offering and negative sentiment regarding fulfillment indicates that scale is currently outpacing operational reliability.
Rank progression
26 active rankings tracked — 30-day window
The rivals identified
Nemeses(1)
GoodRx operates at a massive scale in the prescription savings niche, directly competing for the same price-sensitive pharmacy customer base as PharmEasy.
Differentiators
- Provides real-time price transparency across thousands of local pharmacies to drive consumer savings
- Integrates deep discount card functionality that functions independently of traditional insurance networks
- Maintains a high-velocity release cadence with 22 updates in the last six months alone
Head to head
PharmEasy must pivot from a pure delivery model to a price-transparency platform to neutralize GoodRx's dominance in the prescription savings segment.
Contenders(2)
Practo is a direct competitor in the Indian market, focusing on the intersection of doctor consultations and pharmacy services.
Differentiators
- Aggregates a massive network of verified doctors for online consultations alongside pharmacy fulfillment
- Provides a unified health record system that bridges the gap between consultation and medication delivery
NimbleRx focuses specifically on the pharmacy delivery experience, mirroring PharmEasy's core value proposition with high technical velocity.
Differentiators
- Optimized specifically for rapid, on-demand pharmacy delivery logistics rather than general healthcare services
- Maintains a high release frequency of 26 updates in six months, signaling aggressive feature iteration
Same space(3)
Provides a utility-focused experience centered on medication adherence, which is a key retention driver for pharmacy apps.
Differentiators
- Focuses on pill reminders and health tracking rather than the transactional delivery of goods
- Builds user stickiness through clinical adherence tools rather than retail pharmacy commerce
Competes for the 'front-end' of the healthcare journey by capturing users at the point of booking.
Differentiators
- Specializes in appointment scheduling and provider discovery rather than medication fulfillment
- High-frequency release cycle of 27 updates in six months indicates a focus on UX refinement
A major pharmacy benefit manager that serves as a structural alternative for large-scale medication management.
Differentiators
- Deep integration with insurance providers creates a high barrier to entry for independent pharmacy apps
- Focuses on long-term maintenance medication fulfillment rather than the on-demand delivery model
Compare PharmEasy - Healthcare App against every rival
All rivals in one side-by-side table — identity, store metrics, ratings & sentiment, and strategic intel — plus a head-to-head page for each.
The outtake for PharmEasy - Healthcare App
Strengths to defend, gaps to attack
Core Strengths
- Subscription program drives recurring revenue
- Generic-substitution tool expands addressable market
- NABL-certified lab network ensures clinical trust
Critical Frictions
- Frequent delivery delays
- Opaque refund cycles
- Aggressive generic-substitution tactics
Growth Levers
- Untapped B2B education partnerships
- Wearable health data integration
- Expansion of preventive health packages
Market Threats
- Practo's unified health record system
- GoodRx's superior price-transparency UX
- Rising churn due to fulfillment instability
What are the next best moves?
Rebuild refund transparency logic because opaque refund cycles are a top complaint → reduce financial friction and churn.
Sentiment analysis identifies opaque refunds as a primary driver of negative user experience.
Trade-off: Pause the AI-physiotherapy session expansion — refund friction has a higher impact on core retention.
Audit generic-substitution prompts because users report unwanted pressure to change prescriptions → maintain long-term trust.
User complaints highlight aggressive substitution as a source of distress and trust erosion.
Trade-off: Same-quarter capacity available — no major lever displaced.
A counter-intuitive read
The platform's wide service reach is a liability, not an asset, because the operational complexity of managing lab tests and pharmacy delivery simultaneously prevents the focus needed to fix core fulfillment failures.
Feature Gaps vs Competitors
- Unified health record system (available in Practo but absent here)
- Real-time price transparency across local pharmacies (available in GoodRx but absent here)
Key Takeaways
PharmEasy holds a strong service-first position, but systemic fulfillment failures and aggressive generic-substitution tactics are alienating the user base, so the PM must prioritize operational reliability to prevent churn to competitors like Practo.
Where Is It Heading?
Declining
The Indian medical delivery market is consolidating around platforms that can guarantee fulfillment reliability. PharmEasy's reliance on broad service expansion while fulfillment remains unstable leaves it exposed to competitors like Practo, so the PM must pivot toward operational hygiene to avoid further churn.
Systemic delivery failures and order cancellations erode trust, which directly reduces the lifetime value of long-term loyal customers.
Opaque refund processes create financial friction, leading to increased support tickets and further sentiment decline on the platform.